United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $5,008,396.54 - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $5,008,396.54
U
UTHR• Rothblatt exercises options and sells shares
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on July 14, 2026.
- Rothblatt sold 9,500 shares at weighted-average prices ranging from $524.15 to $532.6 in the same session.
- Direct common stock holdings fell to 40,513 shares following the transactions.
- Direct stock options declined to 1,718 following the exercise.
•
